
Kaynes Technology India Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints
Kaynes Technology India Q1 Results FY27: Uniresearch projects Revenue Rs 939 Cr | PAT Rs 94 Cr (22-analyst consensus). Q4 FY26: Rev Rs 1,243 Cr | PAT Rs 91 Cr.
Updated: 25 Jun 2026 • 10:45 am
Posted by:

The Kaynes Technology India Q1 Results FY27 outlook is anchored on verified Q4 FY26 actuals and Uniresearch analysis applying the 22-analyst FY27 consensus to Q1 FY26 actuals: Revenue Rs 939 Cr (+39.5% YoY) and PAT Rs 94 Cr (+25.3% YoY). Prepared by Ankit Jaiswal.
Click Here – Get Free Investment Predictions
Kaynes Technology India – Uniresearch Prediction
| Metric | Q1 FY26 Actual | Q1 FY27 Uniresearch Prediction | YoY Change | Source |
|---|---|---|---|---|
| Kaynes Technology India Revenue (Rs Cr) | 673 | 939 | +39.5% | Uniresearch | 22-analyst FY27 consensus |
| PAT (Rs Cr) | 75 | 94 | +25.3% | Uniresearch | 22-analyst FY27 consensus |
| Avg Analyst Target | Rs 3,472 | 12-month view | – | 22 analysts |
22-analyst FY27 consensus: Rev +39.5%, PAT +25.3%. Not guaranteed outcomes.
Kaynes Technology India Q4 FY26 Key Metrics
| Metric | Q4 FY26 Actual | YoY Change | Source |
|---|---|---|---|
| Revenue (Rs Cr) | 1,243 | +26.3% YoY | Consolidated quarterly data |
| PAT (Rs Cr) | 91 | -21.6% YoY | Consolidated quarterly data |
Analyst Views on Kaynes Technology India
The 22-analyst FY27 consensus projects revenue growth of +39.5% and profit growth of +25.3% for Kaynes Technology India, with an average 12-month target of Rs 3,472.
Key Watchpoints for Kaynes Technology India
Revenue Delivery
The Kaynes Technology India revenue target is Rs 939 Cr (+39.5% consensus, Q1 FY26 base Rs 673 Cr).
PAT vs Consensus
PAT target Rs 94 Cr (+25.3% vs Q1 FY26 actual Rs 75 Cr). Q4 FY26 PAT was Rs 91 Cr.
Risks to Kaynes Technology India Prediction
Revenue Shortfall
Revenue below +39.5% consensus would miss the Rs 939 Cr target.
PAT Headwinds
Cost pressures or margin contraction could affect PAT vs the +25.3% consensus.
Conclusion: Kaynes Technology India
Uniresearch predicts Kaynes Technology India Revenue Rs 939 Cr and PAT Rs 94 Cr using the 22-analyst FY27 consensus. Track live updates on Univest.
Track Kaynes Technology India Live on the Univest Screener
Download the Univest iOS App or Univest Android App for live alerts.
Disclaimer: Revenue and PAT actuals are sourced from consolidated quarterly financial data. Q1 Results FY27 Uniresearch predictions apply analyst consensus growth rates to verified Q1 FY26 actuals. These are projections, not guaranteed outcomes. Investments in securities are subject to market risk. For educational purposes only. SEBI RA INH000013776.
FAQs on Kaynes Technology India
What is Uniresearch’s PAT prediction for Kaynes Technology India Q1 Results FY27?
Ans. Uniresearch projects Kaynes Technology India Q1 FY27 PAT at Rs 94 Cr (+25.3% vs Q1 FY26 base Rs 75 Cr).
What is the Revenue forecast for Kaynes Technology India Q1 Results FY27?
Ans. Kaynes Technology India Q1 FY27 Revenue projected at Rs 939 Cr (+39.5% vs Q1 FY26 Rs 673 Cr).
What were Kaynes Technology India Q1 Results FY27?
Ans. Q4 FY26: Revenue Rs 1,243 Cr (+26.3% YoY), PAT Rs 91 Cr (-21.6% YoY).
How many analysts cover Kaynes Technology India Q1 Results FY27?
Ans. The Kaynes Technology India prediction uses 22-analyst FY27 consensus, avg target Rs 3,472.
What FY27 consensus was used for Kaynes Technology India Q1 Results FY27?
Ans. Revenue +39.5% and profit +25.3% based on 22-analyst FY27 consensus.
What are risks to Kaynes Technology India Q1 Results FY27?
Ans. Revenue below +39.5% or PAT below +25.3% consensus are the main risks.
What Q1 FY26 base was used for Kaynes Technology India Q1 Results FY27?
Ans. Q1 FY26 Revenue Rs 673 Cr and PAT Rs 75 Cr.
Recent Articles

Sun Pharmaceutical Industries Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints
25 June 2026

Torrent Pharmaceuticals Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints
25 June 2026

Marico Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints
25 June 2026

Gold ETF Falls 2%, Silver ETF Down Up to 4.25%: Bullion Slides as Gold Drops Below $4,000 and Silver Hits $59
25 June 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Sun Pharmaceutical Industries Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints
Torrent Pharmaceuticals Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints
Marico Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints
Gold ETF Falls 2%, Silver ETF Down Up to 4.25%: Bullion Slides as Gold Drops Below $4,000 and Silver Hits $59
Prestige Estates Projects Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints
Popular this week
Sun Pharmaceutical Industries Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints
Torrent Pharmaceuticals Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints
Marico Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints
Gold ETF Falls 2%, Silver ETF Down Up to 4.25%: Bullion Slides as Gold Drops Below $4,000 and Silver Hits $59
Prestige Estates Projects Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas





